What is BHRT and how do I know if I need it?

Short answer BHRT = bioidentical hormone replacement therapy. It means using hormones that are chemically identical to the hormones your body makes (usually estradiol, progesterone, testosterone). BHRT is used to treat hormone-related symptoms such as menopausal hot flashes, night sweats, vaginal dryness, low libido, sleep or mood problems, and for some people with low testosterone. Whether you “need” it depends on your symptoms, medical history, and risks — it’s a shared decision with a clinician.

What BHRT actually is

• “Bioidentical” refers to the chemical structure of the hormone (the same molecule as human estradiol, progesterone, etc.).
• BHRT can be supplied as FDA‑approved products (many estradiol and micronized progesterone preparations are bioidentical) or as compounded custom formulations from compounding pharmacies.
• Forms include pills, patches, gels/creams, vaginal rings/tablets, injections, and subcutaneous pellets.

What it’s commonly used for

• Moderate–severe menopausal symptoms (hot flashes, night sweats, sleep disturbance)
• Vaginal atrophy/urogenital symptoms (dryness, painful intercourse) — local vaginal estrogen is often preferred.
• Low libido or symptoms of low testosterone in women and men (testosterone therapy is more common/established for men).
• Sometimes for prevention of bone loss in early postmenopause (depends on individual risk).

How to know if you might need BHRT

1. Symptoms: Are your hot flashes, night sweats, vaginal symptoms, sleep or mood problems interfering with life? If yes, hormone therapy is a reasonable option to discuss.
2. Medical history and risk assessment: Important factors are age, time since menopause, personal/family history of breast cancer, heart disease, stroke, blood clots, liver disease, and tobacco use. Some conditions make hormone therapy unsafe.
3. Evaluation: A clinician (OB‑GYN, family physician, or endocrinologist with menopause expertise) will review your symptoms, do a physical exam and baseline screening (mammogram where appropriate, blood pressure, lipids). Routine saliva or urine “hormone panel” tests are not recommended for guiding BHRT; serum tests for estradiol or testosterone may be useful in selected cases.
4. Shared decision: If symptoms are significant and your risk profile is acceptable, you and your clinician can weigh benefits and risks and choose dose/formulation.

Safety and evidence highlights

• Evidence shows HRT is effective for menopausal symptoms. The Women’s Health Initiative (WHI) and later analyses informed the risk profile: combined estrogen‑progestin increases breast cancer risk with long-term use, and estrogen (especially when started later) can raise risk of clotting and stroke. Risks vary by age, timing (starting near menopause appears safer than starting >10 years after menopause), dose, and route (transdermal estrogen may have lower clot risk than oral in some studies).
• There is no good evidence that compounded BHRT is safer or more effective than FDA‑approved hormone products. Compounded preparations are not reviewed by the FDA and can vary in potency and purity.
• Vaginal/local estrogen for urogenital symptoms is low‑risk for most women and preferred when symptoms are limited to dryness/pain with sex.

Practical guidance and options (brands/services)

• If you and your clinician decide to use hormone therapy, consider FDA‑approved products first because they have consistent dosing and safety data. Examples:
  • Estradiol patches: Climara, Vivelle‑Dot — consistent dosing; transdermal route may be preferable if clot risk is a concern.
  • Vaginal estradiol: Vagifem (vaginal tablet), Estrace (vaginal cream), Estring (vaginal ring) — effective for local symptoms with lower systemic exposure.
  • Oral micronized progesterone: Prometrium — used to protect the uterus when systemic estrogen is given to women with a uterus.
  • Testosterone for men (if relevant): AndroGel, Testim, Depo‑Testosterone (injectable) — use under specialist supervision. (There are few FDA‑approved testosterone options for women; many clinicians use low‑dose off‑label formulations cautiously.)
• If using a compounding pharmacy, use one that is accredited (look for PCAB accreditation or membership in PCCA and state pharmacy board standing) and discuss the reasons you need a compounded product.

Alternatives to hormones

• Non‑hormonal options for hot flashes: SSRIs/SNRIs (paroxetine is FDA‑approved for hot flashes), gabapentin, clonidine, lifestyle measures (cooling, layered clothing).
• For painful intercourse/vaginal dryness: vaginal moisturizers and lubricants; ospemifene (oral SERM) for dyspareunia in some women.
• Bone health: calcium/vitamin D and specific osteoporosis medications when indicated.

How to proceed

1. Track your symptoms (frequency, severity, impact).
2. Make an appointment with a clinician experienced in menopause (OB‑GYN, family physician, or endocrinologist). The North American Menopause Society (NAMS) and clinics at Mayo Clinic or Cleveland Clinic have reliable patient resources and specialists.
3. Discuss risks, alternatives, whether to try FDA‑approved preparations first, monitoring plans, and a target duration/dose (start low and reassess).

If you want, tell me: your age, sex, main symptoms, medical history (breast cancer, blood clots, heart disease, liver disease), and whether you’re already on any hormones — I can give more tailored advice and help you prepare questions to ask your clinician.